Christopher Richard, CEO of Lexaria Bioscience Corp. ($LEXX), made one open market purchase of common shares worth $13,641 in the last 365 days, with the most recent on July 29, 2025. His buying activity ranks 4,099th among 4,983 insiders in our database, below the average purchase amount of $1.46 million across 3.29 transactions. He reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 29, 2025 | Lexaria Bioscience Corp. | $LEXX | CHRISTOPHER RICHARD | Chief Executive Officer | P | common shares | 15000 | $0.91 | 115,000.0000 | 0 | 15.00% | 0.00% |
| May 15, 2025 | Lexaria Bioscience Corp. | $LEXX | CHRISTOPHER RICHARD | Chief Executive Officer | A | Stock Options | 150000 | $0.00 | 550,000.0000 | 0 | 37.50% | 0.00% |
| Dec. 2, 2024 | Lexaria Bioscience Corp. | $LEXX | CHRISTOPHER RICHARD | Chief Executive Officer | P | common shares | 22828 | $2.24 | 22,828.0000 | 0 | 9999.99% | 0.00% |
| Dec. 3, 2024 | Lexaria Bioscience Corp. | $LEXX | CHRISTOPHER RICHARD | Chief Executive Officer | P | common shares | 27172 | $2.47 | 50,000.0000 | 0 | 119.03% | 0.00% |